All Type of News
NHI coverage extension for Zelmac in combined therapy.The NHI reimbursement seems to be extended to a combination therapy of Zelmac with other antispasmodics and GIT regulator drugs.
Novartis Korea said that Zelmac (tagaserod ...
|
SY Pharmtech to run technology transfer business.
While the government mulls a third party (toll) manufacturing permission for pharmaceutical products, SY pharmtech (president: Choi Soo-young) announced on Feb. 2 that the company is trying to run a technology transfe...
KFDA to provide drug contra-indicative informations.
The KFDA planned a drug information support for contra-indications of combined drugs this year and other appropriate informations until 2010 according to "Information Supports for Appropriate Drug Uses" announced on J...
Sudo to appoint Park Sang-young as a strategic project director.
Sudo pharmaceutical company announced that Mr. Park Sang-young (45 years old), the former vice chairman of Korea Science Press Association was appointed as the standing director in charge of the strategic business pro...
Mr. Moon Chang-jin internally to elect as new KFDA chief commissioner.The government announced on Jan. 31 that Mr. Moon Chang-jin, the former MOHW's Policy Publicity and Administration's chief officer was internally named to the KFDA chief commiss...
|
Boryung reports slow sales and profit down in 2005.
Boryung pharmaceutical company announced the 2005 financial reports at 167,979 million won of sales, 5.9% down from the previous year, 6,839 million won of operating incomes and 5,938 million won of ordinary incomes, ...
Big public tenders to invite by Samsung and WAMC.
Samsung Medical Corporation and Workers Accident Medical Corporation announced to invite the public tenders for the purchase of drugs on Feb. 6, which showed a big business of keenly attracting wholesaler's interests....
CJ to declare a vision for top global pharmaceutical management.CJ Pharmaceutical Division took a declaration ceremony of "The Korea Top Global Pharmaceutical Company" to the Korea as well as the world at Daemyung Vivaldi park on Jan. 20 and...
|
Inseong Info to associate with KTF for mobile diabetic controls.
Inseong Information Inc., an IT specialized company, announced that the company had associated with KTF for a commercialized mobile diabetic control service called "Hicare Doctor's Diabetic Control" starting from Feb....
Medipost/Samsung Hospital joint to develop a new composite for lung disease.
Medipost, a biotech company, has developed a therapeutic composite material for the treatment of lung diseases by the use of adult stem cells in association with the Dept. of Pediatrics, Seoul Samsung Hospital.
The...
